ScholarIQanswers from OpenAlex & ORCID
Cloud P. Paweletz
ResearcherPublications, citations & collaboration network
Cloud P. Paweletz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Cloud P. Paweletz have?
ScholarIQindexed works
Cloud P. Paweletz has 760 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Cloud P. Paweletz have?
ScholarIQcitation count
Cloud P. Paweletz has 22,827 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Cloud P. Paweletz?
ScholarIQh-index
Cloud P. Paweletz has an h-index of 73 in OpenAlex.
What is the i10-index of Cloud P. Paweletz?
ScholarIQi10-index
Cloud P. Paweletz has an i10-index of 145 in OpenAlex.
What is the ORCID of Cloud P. Paweletz?
ScholarIQorcid
The ORCID for Cloud P. Paweletz is on the source record.
What is the OpenAlex record for Cloud P. Paweletz?
ScholarIQopenalex
The OpenAlex for Cloud P. Paweletz is on the source record.
What are the most-cited papers on Cloud P. Paweletz?
ScholarIQmost cited works
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard, John P. Ray, Carl G. de Boer, Russell W. Jenkins, David Lieb, Jonathan Chen, Dennie T. Frederick, Michal Barzily-Rokni, Samuel S. Freeman, Alexandre Reuben, Paul Hoover, Alexandra–Chloé Villani, Elena V. Ivanova, Andrew Portell, Patrick H. Lizotte, Amir Reza Aref, Jean-Pierre Eliane, Marc R. Hammond, Hans Vitzthum, Shauna Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha M. Reddy, Zachary A. Cooper, Cloud P. Paweletz, David A. Barbie, Anat Stemmer‐Rachamimov, Keith T. Flaherty, Jennifer A. Wargo, Genevieve M. Boland, Ryan J. Sullivan, Gad Getz, Nir Hacohen
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip, Byoung Chul Cho, Daniel Stetson, Brian Dougherty, Zhongwu Lai, Aleksandra Markovets, Ana Vivancos, Yanan Kuang, Dalia Ercan, Sarah E Matthews, Mireille Cantarini, J. Carl Barrett, Pasi A. Jänne, Geoffrey R. Oxnard
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front
Cloud P. Paweletz, Lu Charboneau, Verena E. Bichsel, Nicole L. Simone, Tina Chen, John W. Gillespie, Michael R. Emmert‐Buck, Mark J. Roth, Emanuel F. Petricoin, Lance A. Liotta
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer
Geoffrey R. Oxnard, Kenneth S. Thress, Ryan S. Alden, Rachael Lawrance, Cloud P. Paweletz, Mireille Cantarini, James Chih‐Hsin Yang, J. Carl Barrett, Pasi A. Jänne
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Jiehui Deng, Eric S. Wang, Russell W. Jenkins, Shuai Li, Ruben Dries, Kathleen Yates, Sandeep Chhabra, Wei Huang, Hongye Liu, Amir Reza Aref, Elena V. Ivanova, Cloud P. Paweletz, Michaela Bowden, Chensheng W. Zhou, Grit S. Herter-Sprie, Jessica A. Sorrentino, John Bisi, Patrick H. Lizotte, Ashley A. Merlino, Max M. Quinn, Lauren E. Bufe, Annan Yang, Y. Zhang, Hua Zhang, Peng Gao, Ting Chen, Megan E. Cavanaugh, Amanda J. Rode, Eric Haines, Patrick J. Roberts, Jay C. Strum, William G. Richards, Jochen H. Lorch, Sareh Parangi, Viswanath Gunda, Genevieve M. Boland, Raphael Bueno, Sangeetha Palakurthi, Gordon J. Freeman, Jerome Ritz, W. Nicholas Haining, Norman E. Sharpless, Haribabu Arthanari, Geoffrey I. Shapiro, David A. Barbie, Nathanael S. Gray, Kwok‐Kin Wong